These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22850878)

  • 1. A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis.
    Somm E; Bonnet N; Martinez A; Marks PM; Cadd VA; Elliott M; Toulotte A; Ferrari SL; Rizzoli R; Hüppi PS; Harper E; Melmed S; Jones R; Aubert ML
    J Clin Invest; 2012 Sep; 122(9):3295-306. PubMed ID: 22850878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GHRH receptor-targeted botulinum neurotoxin selectively inhibits pulsatile GH secretion in male rats.
    Leggett J; Harper E; Waite E; Marks P; Martinez A; Lightman S
    Endocrinology; 2013 Sep; 154(9):3305-18. PubMed ID: 23825127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
    Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative inhibition of the GH/IGF-I axis obtained with either the targeted secretion inhibitor SXN101959 or the somatostatin analog octreotide in growing male rats.
    Somm E; Bonnet N; Zizzari P; Tolle V; Toulotte A; Jones R; Epelbaum J; Martinez A; Hüppi PS; Aubert ML
    Endocrinology; 2013 Nov; 154(11):4237-48. PubMed ID: 24029240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides).
    Wang B; Qin C; Zhang C; Jia J; Sun C; Li W
    Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of the GHRH/GH/IGF1 axis in a mouse model of Börjeson-Forssman-Lehman syndrome.
    McRae HM; Eccles S; Whitehead L; Alexander WS; Gécz J; Thomas T; Voss AK
    Development; 2020 Oct; 147(21):. PubMed ID: 32994169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
    García-Tornadú I; Rubinstein M; Gaylinn BD; Hill D; Arany E; Low MJ; Díaz-Torga G; Becu-Villalobos D
    J Endocrinol; 2006 Sep; 190(3):611-9. PubMed ID: 17003262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic dissection of IGF1-dependent and -independent effects of permanent GH excess on postnatal growth and organ pathology of mice.
    Blutke A; Schneider MR; Renner-Müller I; Herbach N; Wanke R; Wolf E
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):88-98. PubMed ID: 25017732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse with targeted ablation of the growth hormone-releasing hormone gene: a new model of isolated growth hormone deficiency.
    Alba M; Salvatori R
    Endocrinology; 2004 Sep; 145(9):4134-43. PubMed ID: 15155578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?
    Riedel M; Günther T; von zur Mühlen A; Brabant G
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):233-9. PubMed ID: 1358484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in mRNA concentrations of pituitary receptors for growth hormone-releasing hormone and growth hormone secretagogues after neonatal monosodium glutamate treatment.
    Kovacs M; Kineman RD; Schally AV; Flerko B; Frohman LA
    J Neuroendocrinol; 2000 Apr; 12(4):335-41. PubMed ID: 10718930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse.
    Alba M; Fintini D; Bowers CY; Parlow AF; Salvatori R
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E762-7. PubMed ID: 15985453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-acting antagonists of growth hormone (GH)-releasing hormone on GH and cyclic adenosine 3',5'-monophosphate release in superfused rat pituitary cells.
    Horváth JE; Zarándi M; Groot K; Schally AV
    Endocrinology; 1995 Sep; 136(9):3849-55. PubMed ID: 7649091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial reversibility of growth hormone (GH) deficiency in the GH-releasing hormone (GHRH) knockout mouse by postnatal treatment with a GHRH analog.
    Alba M; Schally AV; Salvatori R
    Endocrinology; 2005 Mar; 146(3):1506-13. PubMed ID: 15564325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.
    Doi N; Hirotani C; Ukai K; Shimada O; Okuno T; Kurasaki S; Kiyofuji T; Ikegami R; Futamata M; Nakagawa T; Ase K; Chihara K
    Arzneimittelforschung; 2004; 54(12):857-67. PubMed ID: 15646370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of ethanol on the growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-I axis in the rat.
    Soszynski PA; Frohman LA
    Endocrinology; 1992 Dec; 131(6):2603-8. PubMed ID: 1359962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
    Bowers CY; Granda-Ayala R
    Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content.
    Kamegai J; Tamura H; Shimizu T; Ishii S; Tatsuguchi A; Sugihara H; Oikawa S; Kineman RD
    Endocrinology; 2004 Aug; 145(8):3731-8. PubMed ID: 15087428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro pituitary GH secretion after GHRH, forskolin, dibutyryl cyclic-adenosine 3',5'-monophosphate and phorbol 12-myristate 13-acetate stimulation in long-term orchidectomized rats.
    Tena-Sempere M; Pinilla L; Aguilar E
    J Mol Endocrinol; 1996 Feb; 16(1):81-8. PubMed ID: 8672236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice with an RGS-insensitive Gα
    Omouessi ST; Leipprandt JR; Akoume MY; Charbeneau R; Wade S; Neubig RR
    Mol Cell Endocrinol; 2021 Feb; 521():111098. PubMed ID: 33278490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.